Pacgen Life Science Corporation announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was CAD 104,064 compared to CAD 99,914 a year ago. Net loss was CAD 57,859 compared to CAD 65,564 a year ago. For the nine months, total revenue was CAD 344,647 compared to CAD 340,443 a year ago. Net loss was CAD 210,270 compared to CAD 220,903 a year ago.